Streptomyces as a Prominent Resource of Future Anti-MRSA Drugs.

ABSTRACT: Methicillin-resistant Staphylococcus aureus (MRSA) pose a significant health threat as they tend to cause severe infections in vulnerable populations and are difficult to treat due to a limited range of effective antibiotics and also their ability to form biofilm. These organisms were once limited to hospital acquired infections but are now widely present in the community and even in animals. Furthermore, these organisms are constantly evolving to develop resistance to more antibiotics. This results in a need for new clinically useful antibiotics and one potential source are the Streptomyces which have already been the source of several anti-MRSA drugs including vancomycin. There remain large numbers of Streptomyces potentially undiscovered in underexplored regions suc

SUBMITTER: Kemung HM 

PROVIDER: S-EPMC6165876 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature